SPRING – rolling tri-therapy combinations of targeted drugs in second line of metastatic NSCLC
SPRING – rolling tri-therapy combinations of targeted drugs in second line of metastatic NSCLC
TargomiRs show promise in phase I study of malignant mesothelioma
SPECTAlung: improving clinical trial access for patients with thoracic tumours
Cancer genomics of urothelial cancer and fibroepithelial tumors of the breast
Ibrutinib combined with bendamustine plus rituximab in previously treated CLL and SLL
ecancermedicalscience editor's choice for June 2015
Diabetes & breast cancer
Radioterapia Intraoperatoria con Electrones (ELIOT) en Cáncer de Mama: Experiencia del Instituto Europeo de Oncología
Epidemiología y Factores de Riesgo del Cáncer de Mama en México
Breast Cancer in Latin America
Radioterapia personalizada: cáncer de mama 2015. El paradigma de la adaptación bio-tecnológica
Chemoresistance and residual disease promoted by DNMT3A R882 in AML